Cargando…
Blood-Brain Barrier Impairment in an Animal Model of MPS III B
BACKGROUND: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of α-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of...
Autores principales: | Garbuzova-Davis, Svitlana, Louis, Michael K., Haller, Edward M., Derasari, Hiranya M., Rawls, Ashley E., Sanberg, Paul R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049764/ https://www.ncbi.nlm.nih.gov/pubmed/21408219 http://dx.doi.org/10.1371/journal.pone.0016601 |
Ejemplares similares
-
Blood-brain barrier impairment in MPS III patients
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2013) -
Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014) -
Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2007) -
Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018) -
Blood-Brain Barrier Alterations Provide Evidence of Subacute Diaschisis in an Ischemic Stroke Rat Model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2013)